AbbVie (Germany) Today
| 4AB Stock | EUR 173.96 1.94 1.10% |
Performance0 of 100
| Odds Of DistressLess than 9
|
AbbVie is trading at 173.96 as of the 30th of November 2024. This is a 1.1 percent decrease since the beginning of the trading day. The stock's lowest day price was 172.52. AbbVie has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for AbbVie Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. The company has 1.77 B outstanding shares. More on AbbVie Inc
Moving against AbbVie Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AbbVie Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AbbVie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AbbVie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman of the Board, CEO | Richard Gonzalez |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
AbbVie Inc (4AB) is traded on Frankfurt Exchange in Germany and employs 50,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 256.3 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AbbVie's market, we take the total number of its shares issued and multiply it by AbbVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AbbVie Inc classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 1.77 B outstanding shares.
AbbVie Inc has accumulated about 5.23 B in cash with 24.94 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54.
Check AbbVie Probability Of Bankruptcy
Ownership AllocationAbbVie holds a total of 1.77 Billion outstanding shares. The majority of AbbVie Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AbbVie Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AbbVie. Please pay attention to any change in the institutional holdings of AbbVie Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AbbVie Ownership Details
AbbVie Inc Risk Profiles
Although AbbVie's alpha and beta are two of the key measurements used to evaluate AbbVie's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.22 | |||
| Semi Deviation | 2.58 | |||
| Standard Deviation | 2.19 | |||
| Variance | 4.81 |
AbbVie Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AbbVie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Additional Information and Resources on Investing in AbbVie Stock
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.